Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer
2023 · JAMA · 125 citations
https://doi.org/10.1001/jama.2023.7843
T
Tzu‐Fei Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
192
Papers
5.0K
Citations
31
h-index
64
i10-index
Tzu‐Fei Wang is an academic researcher from University of Ottawa. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Atrial Fibrillation Management and Outcomes & Central Venous Catheters and Hemodialysis. The author has an h-index of 31, co-authored 164 publications.
ORCID: 0000-0003-2407-9000Papers by this author
worksManaging thrombosis in cancer patients
2018 · Research and Practice in Thrombosis and Haemostasis · 54 citations
https://doi.org/10.1002/rth2.12102
Anticoagulation practice patterns in COVID‐19: A global survey
2020 · Research and Practice in Thrombosis and Haemostasis · 45 citations
https://doi.org/10.1002/rth2.12414
Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older Adults
2021 · CJC Open · 24 citations
https://doi.org/10.1016/j.cjco.2021.11.002
Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis
2023 · Journal of Thrombosis and Haemostasis · 14 citations
https://doi.org/10.1016/j.jtha.2023.11.017
Anticoagulant management of cancer-associated thrombosis and thrombocytopenia: a retrospective chart review
2025 · Research and Practice in Thrombosis and Haemostasis · 6 citations
https://doi.org/10.1016/j.rpth.2025.102684
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat